In CKD, once-daily empagliflozin reduced progression of kidney disease or CV death at 2 y

EMPA-KIDNEY Collaborative Group; Herrington WG, Staplin N, Wanner C, et al. N Engl J Med. 2023;388:117-27. 36331190.

Saved in:
Bibliographic Details
Published inAnnals of internal medicine Vol. 176; no. 3; p. JC26
Main Authors Kwong, Y Diana, Hsu, Chi-Yuan
Format Journal Article
LanguageEnglish
Published United States 01.03.2023
Subjects
Online AccessGet more information

Cover

Loading…
Abstract EMPA-KIDNEY Collaborative Group; Herrington WG, Staplin N, Wanner C, et al. N Engl J Med. 2023;388:117-27. 36331190.
AbstractList EMPA-KIDNEY Collaborative Group; Herrington WG, Staplin N, Wanner C, et al. N Engl J Med. 2023;388:117-27. 36331190.
Author Hsu, Chi-Yuan
Kwong, Y Diana
Author_xml – sequence: 1
  givenname: Y Diana
  surname: Kwong
  fullname: Kwong, Y Diana
  organization: University of California, San Francisco, San Francisco, California, USA (Y.D.K., C.H.)
– sequence: 2
  givenname: Chi-Yuan
  surname: Hsu
  fullname: Hsu, Chi-Yuan
  organization: University of California, San Francisco, San Francisco, California, USA (Y.D.K., C.H.)
BackLink https://www.ncbi.nlm.nih.gov/pubmed/36877974$$D View this record in MEDLINE/PubMed
BookMark eNo1j8tKxDAUQIMozkPBL5D7AVbbJM1jKXXU0QE3Krga0uR2jLZJaTqL-vUK6urAWRw4C3IYYkBCzor8UjIqrh4oy_I81wdkXpRMZ0zmfEYWKX38WKaoOiYzJpSUWvI5eVsHqB5vLiAGi5kzvp0Au97sWt-08csHGNDtLTroh7gbMCUfA8QGPr0LOIHzCU1CiANUr-DQjO9gRqAwnZCjxrQJT_-4JC-3q-fqPts83a2r601mKedjJutc6KZmQnONWhXCKY7Clo2VQhelEaxUwhXC1rQsNONSGSpNjVQIQ7W0dEnOf7v9vu7QbfvBd2aYtv-P9BsFrlAq
ContentType Journal Article
DBID CGR
CUY
CVF
ECM
EIF
NPM
DOI 10.7326/J23-0009
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
DatabaseTitleList MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod no_fulltext_linktorsrc
Discipline Medicine
EISSN 1539-3704
ExternalDocumentID 36877974
Genre Comment
Journal Article
GroupedDBID ---
..I
.55
.GJ
.XZ
08G
1CY
23M
2WC
354
36B
39C
3O-
3V.
4.4
53G
5GY
5RE
5RS
6J9
7RV
7X7
88E
8C1
8F7
8FI
8FJ
8G5
8R4
8R5
AAKAS
AAQOH
AAQQT
AARDX
AAWTL
AAYOK
ABBLC
ABCQX
ABJNI
ABOCM
ABPMR
ABUWG
ACBNA
ACGFO
ACGFS
ADBBV
ADZCM
AEGXH
AENEX
AERZD
AFCHL
AFFNX
AFKRA
AHJKT
AHMBA
AI.
AIAGR
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AQUVI
ASPBG
AVWKF
AZFZN
AZQEC
BCR
BCU
BEC
BENPR
BKEYQ
BKNYI
BLC
BPHCQ
BTJBQ
BVXVI
BZLQD
C1A
C45
CCPQU
CGR
CUY
CVF
DWQXO
E3Z
EBS
ECM
EIF
EJD
EMB
EMOBN
EX3
F5P
FEDTE
FYUFA
G8K
GNUQQ
GUQSH
H13
HMCUK
HVGLF
H~9
IH2
J5H
K-O
K9-
L7B
LPU
M0R
M0T
M1P
M2O
M5~
MV1
MVM
N4W
NAPCQ
NPM
OBH
OCB
OFXIZ
OGEVE
OHH
OHT
OVD
OVIDX
P2P
PCD
PQQKQ
PROAC
PSQYO
Q2X
RWL
RXW
S0X
SJFOW
SJN
SV3
TAE
TEORI
TPH
TR2
TWZ
UKHRP
UKR
VH1
VVN
WH7
WOQ
WOW
X6Y
X7M
XOL
YFH
YOC
YQJ
YYP
ZGI
ZXP
ZY1
~H1
ID FETCH-LOGICAL-c244t-7b069fb36949e9816d84e6c5fc76915a63586d16cb25193478a27abe266a297c2
IngestDate Sat Sep 28 08:15:24 EDT 2024
IsPeerReviewed true
IsScholarly true
Issue 3
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c244t-7b069fb36949e9816d84e6c5fc76915a63586d16cb25193478a27abe266a297c2
PMID 36877974
ParticipantIDs pubmed_primary_36877974
PublicationCentury 2000
PublicationDate 2023-03-00
PublicationDateYYYYMMDD 2023-03-01
PublicationDate_xml – month: 03
  year: 2023
  text: 2023-03-00
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Annals of internal medicine
PublicationTitleAlternate Ann Intern Med
PublicationYear 2023
References 36331190 - N Engl J Med. 2023 Jan 12;388(2):117-127
References_xml
SSID ssj0003828
Score 2.4581413
Snippet EMPA-KIDNEY Collaborative Group; Herrington WG, Staplin N, Wanner C, et al. N Engl J Med. 2023;388:117-27. 36331190.
SourceID pubmed
SourceType Index Database
StartPage JC26
SubjectTerms Cardiovascular Diseases
Diabetes Mellitus, Type 2 - complications
Diabetes Mellitus, Type 2 - drug therapy
Humans
Renal Insufficiency, Chronic - complications
Renal Insufficiency, Chronic - drug therapy
Risk Factors
Title In CKD, once-daily empagliflozin reduced progression of kidney disease or CV death at 2 y
URI https://www.ncbi.nlm.nih.gov/pubmed/36877974
Volume 176
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnZ3LT9swHMetAhLiMjH2HkM-7NaZNXHqxxFlQ6VsnADRE7JjG1XrUrSlmsZfv58faUsZiO0SVbHaRv643_7s3wuh90a4TFaZICCBjhQ0N0SA3UBEZnXf9YRWNkRbnLDBWTG86F90Ol-WopZmjd6vbv6aV_I_VOEecPVZsv9Adv6hcANeA1-4AmG4PorxUd0tjz_5WfLJh8Qof1Zh4Qd-NRm7yfQm5KqYmXfxhzisWIPD24ffxqYGNUjuGR-UXp53jTcHfXZj3r3l7F0UWR7H88PJHZf88a8U2jsCEVX1XOsHP2fRqT8mo1laiOmMIaeLIKt92-qiBC2KnYLnwhk7t6QVQpdkcFjGNPhVfeY0dJQc-m_ohbIIzRKm6--BE2WCcxl79zw8ulIpux1aQ2tceM078Sc36V-ZwtYyFh_2D_GxfYQttNm-bWVjEQyM0230JO0M8EHE_BR1bL2DNr-miX6GRkc1Btof8II1vsUaJ9Z4iTWeOhxZ48QaT3_g8hwH1lg1OMe_n6Ozw8-n5YCkxhikAmusIVz3mHSaMllIK0XGjCgsq_qu4kxmfQVGpGAmY5X2ecm04ELlXGkLxpjKJa_yF2i9ntb2FcKg35lU0veO9ZZoJYziKuNWUico1_Y1ehkn5fI6Vj-5bKfrzb0jb9HWYhHtog0Ha9S-A9ut0XsByh_VL0Cx
link.rule.ids 783
linkProvider National Library of Medicine
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=In+CKD%2C+once-daily+empagliflozin+reduced+progression+of+kidney+disease+or+CV+death+at+2+y&rft.jtitle=Annals+of+internal+medicine&rft.au=Kwong%2C+Y+Diana&rft.au=Hsu%2C+Chi-Yuan&rft.date=2023-03-01&rft.eissn=1539-3704&rft.volume=176&rft.issue=3&rft.spage=JC26&rft_id=info:doi/10.7326%2FJ23-0009&rft_id=info%3Apmid%2F36877974&rft_id=info%3Apmid%2F36877974&rft.externalDocID=36877974